DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 64 · 1990 DOI: 10.1055/s-008-40439

Review Article

344
Märki, Walter E; Wallis, Robert B: The Anticoagulant and Antithrombotic Properties of Hirudins

Original Article

349
Rodeghiero, Francesco; Castaman, Giancarlo; Tosetto, Alberto: Von Willebrand Factor Antigen Is Less Sensitive than Ristocetin Cofactor for the Diagnosis of Type I von Willebrand Disease -Results Based on an Epidemiological Investigation
353
Solano, C; Cobcroft, R G; Scott, D C: Prediction of Vitamin K Response Using the Echis Time and Echis-Prothrombin Time Ratio
358
Cattaneo, Marco; Tenconi, Paola M; Alberca, Ignazio; Garcia, Vicente Vicente; Mannucci, Pier Mannuccio: Subcutaneous Desmopressin (DDAVP) Shortens the Prolonged Bleeding Time in Patients with Liver Cirrhosis
361
Nanninga, P B; van Teunenbroek, A; Veenhof, C H N; Büller, H R; ten Cate, J W: Low Prevalence of Coagulation and Fibrinolytic Activation in Patients with Primary Untreated Cancer
365
Toulon, P; Bardin, J M; Blumenfeld, N M: Increased Heparin Cofactor II Levels in Women Taking Oral Contraceptives
369
Lane, I F; Lumley, P; Michael, M F; Peters, A M; McCollum, C N: A Specific Thromboxane Receptor Blocking Drug, AH23848, Reduces Platelet Deposition on Vascular Grafts in Man
374
Farrugia, A; Douglas, S; James, J; Whyte, G; Herrington, R: Use of Plasma with High Levels of lonised Calcium in the Production of Model Scale Goagulation Factor Concentrates
379
Poort, S R; Briët, E; Bertina, R M; Reitsma, P H: Two Mutations of the Factor IX Gene Including a Donor Splice Consensus Deletion and a Point Mutation in a Dutch Patient with Severe Hemophilia B
385
Hansen, John-Bjarne; Wilsgård, Line; Olsen, Jan Ole; Østerud, Bjarne: Formation and Persistence of Procoagulant and Fibrinolytic Activities in Circulation after Strenuous Physical Exercise
390
Binnema, D J; Dooijewaard, G; van Iersel, J J L; Turion, P N C; Kluft, C: The Contact-System Dependent Plasminogen Activator from Human Plasma: Identification and Characterization
398
Gaffney, P J; Heath, A B: A Collaborative Study to Establish a Standard for High Molecular Weight Urinary-Type Plasminogen Activator (HMW/u-PA)
402
Oethinger, M D; Seifried, E: In Vitro Effects of Urokinase — Prevention by Different Inhibitors
407
George, F; Pourreau-Schneider, N; Boutiere, B; Arnoux, D; Boutiére, B; Berthois, Y; Martin, P M; Sampol, J: Concomitant Secretion by A431 Cells of Tissue Plasminogen Activator and a Specific Inhibitor Masks EGF Modulation of tPA Activity
412
Fujii, Satoshi; Lucore, Charles L; Hopkins, William E; Billadello, Joseph J; Sobel, Burton E: Induction of Synthesis of Plasminogen Activator Inhibitor Type-1 byTissue-Type Plasminogen Activator in Human Hepatic and Endothelial Cells
420
Grulich-Henn, Jürgen; Preissner, Klaus T; Müller-Berghaus, Gert: Heparin Stimulates Fibrinolysis in Mesothelial Cells by Selective lnduction of Tissue-Plasminogen Activator but not Plasminogen Activator Inhibitor-l Synthesis
426
Abercrombie, David M; Buchinski, Bruce; Salvato, Kathleen A; Vovis, Gerald F; Stump, David C; Broeze, Robert J: Fibrin Specific Thrombolysis by Two-Chain Urokinase-Type Plasminogen Activator Cleaved after Arginine 156 by Thrombin
433
Keber, D; Blinc, A; Fettich, J: lncrease of Tissue Plasminogen Activator in Limbs During Venous Occlusion : A Simple Haemodynamic Model
438
Voytik, Sherry; Badylak, Stephen F; Burke, Sandra; Klabunde, Richard E; Henkin, Jack; Simmons, Abby: The Protective Effect of Heparin in a Dog Model of Rethrombosis Following Pharmacologic Thrombolysis
445
Senatore, F; Shankar, H; Ho, C H; Avantsa, S; Allon, M; Posteraro, R: Effect of Soluble and Immobilized Plasmin on Fibrinogen and Platelets
450
Sabovic, M; Lijnen, H R; Keber, D; Collen, D: Correlation between Progressive Adsorption of Plasminogen to Blood Clots and Their Sensitivity to Lysis
455
Jones, A J S; Meunier, A M: A Precise and Rapid Microtitre Plate Clot Lysis Assay: Methodology, Kinetic Modeling and Measurement of Catalytic Constants for Plasminogen Activation during Fibrinolysis
464
Lindhout, Theo; Blezer, Ron; Coenraad Hemker, H: The Anticoagulant Mechanism of Action of Recombinant Hirudin (CGP 39393) in Plasma
469
Stenziger, Werner; Kehrel, Beate; van de Loo, Jürgen: Identification of Platelet Antigens by Immunoprecipitation of Unlabelled Platelet Glycoproteins
473
Chen, Shih-Luen; Yang, Wu-Chang; Huang, Tung-Po; Wann, Shiang; Teng, Che-ming: Chlorobutanol, a Preservative of Desmopressin, Inhibits Human Platelet Aggregation and Release In Vitro

Scientific and Standardization Committee Communications

478
Exner, Thomas; Triplett, Douglas A; Taberner, David A; Howard, Margaret A; Harris, E Nigel: Scientific and Standardization Committee Communications Comparison of Test Methods for the Lupus Anticoagulant: International Survey on Lupus Anticoagulants-I (ISLA-1)

Letter to the Editor

485
Grodzinska, Lilia; Hafner, Gerd; Darius, Harald; Medizinische Klinik, II: Effest of Molsidomine on t-PA and PAI Activity in Man: A Double Blind, Placebo Controlled Study
486
O’Brien, J R; Ethwrington, M D: How Much Aspirin?
487
Maschio, Aldo Del; Bazzoni, Gianfranco; Bertelá, Vittorio: Investigation of Platelet/Leukocyte Interaction by Whole Blood Aggregometry
488
Lionnet, F; Gouault-Heilmann, M; Azoulay, C; Lacorte, J M; Schaeffer, A: Auto-lmmune Eactor Vlll : G lnhibitor Durably Responsive to lmmunoglobulin: A New Case
490
Dautzenberg, M D; Bara, L; Cornu, P; Samama, M: Specific Anti-Xa Activity of LMWH (Kabi 2165, CY216 PK 10169) Against the First International Standard of LMWH: A Collaborative Study